Table 3.
Competing risk cumulative incidence rates (univariate analysis) |
Competing risk regression hazard ratios (multivariable analysis) |
|||||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
10-yr CBC risk |
p- value* |
10-yr IBTR risk |
p- value** |
CBCHR | p- value |
IBTR HR |
p- value |
|
Age, yrs | ||||||||
≤49 | 6.1% | 0.9 | 17.6% | 0.002 | ref | 0.72 | ref | 0.002 |
≥50 | 5.6% | 13.2% | 0.93 | 0.68 | ||||
| ||||||||
Family history | ||||||||
No | 5.4% | 0.3 | 14.0% | 0.47 | ref | 0.7 | ref | 0.54 |
Yes | 6.2% | 15.1% | 1.08 | 1.08 | ||||
| ||||||||
Presentation | ||||||||
Radiologic | 6.3% | 0.01 | 13.6% | 0.001 | ref | 0.06 | ref | 0.013 |
Clinical | 2.3% | 20.1% | 0.47 | 1.49 | ||||
| ||||||||
Nuclear grade | ||||||||
Low | 5.2% | 0.4 | 12.7% | 0.1 | ref | 0.49 | ref | 0.002 |
Intermediate/high | 6.2% | 14.5% | 1.21 | 1.65 | ||||
| ||||||||
Year of surgery | ||||||||
≤1998 | 4.1% | 0.09 | 19.3% | < 0.0001 | ref | 0.1 | ref | 0.037 |
≥1999 | 6.6% | 13.2% | 1.45 | 0.75 | ||||
| ||||||||
Radiation | ||||||||
No | 5.2% | 0.2 | 19.5% | < 0.0001 | ref | 0.82 | ref | <0.0001 |
Yes | 6.3% | 10.4% | 1.05 | 0.46 | ||||
| ||||||||
Endocrine therapy | ||||||||
No | 6.5% | 0.2 | 16.5% | < 0.0001 | ref | 0.07 | ref | 0.004 |
Yes | 3.2% | 7.8% | 0.61 | 0.59 |
p-value for each co-variate for risk of CBC; calculated using Gray’s test
p-value for each co-variate for risk of IBTR; calculated using Gray’s test
HR = hazard ratio
IBTR = ipsilateral breast tumor recurrence
CBC = contralateral breast cancer